Can you provide the last earnings date for BIONANO GENOMICS INC?
BIONANO GENOMICS INC (BNGO) last reported earnings on 11/13/2025.
NASDAQ:BNGO • US09075F4046
Past quarterly earnings results for BIONANO GENOMICS INC (BNGO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -1.59 | -1.95 | 18.39% | 93.38% | 7.367M | 7.008M | 5.12% | -9.75% |
| Q2 2025 | -1.99 | -2.46 | 19.21% | 84.92% | 6.733M | 6.968M | -3.37% | -13.36% |
| Q1 2025 | -1.15 | -3.08 | 62.68% | 96.24% | 6.457M | 6.358M | 1.56% | -26.37% |
| Q4 2024 | -15.83 | -6.12 | -158.66% | 35.65% | 8.163M | 6.324M | 29.08% | -23.86% |
| Q3 2024 | -24.00 | -12.85 | -86.74% | 60.00% | 8.163M | 8.011M | 1.90% | -12.40% |
| Q2 2024 | -13.20 | -25.50 | 48.24% | 82.26% | 7.771M | 8.163M | -4.80% | -10.29% |
| Q1 2024 | -30.60 | -39.47 | 22.48% | 57.50% | 8.769M | 8.662M | 1.24% | 18.26% |
| Q4 2023 | -24.60 | -53.40 | 53.93% | 68.46% | 10.721M | 10.797M | -0.70% | 30.43% |
| Q3 2023 | -60.00 | -59.36 | -1.07% | 9.09% | 9.318M | 9.265M | 0.57% | 29.06% |
| Q2 2023 | -74.40 | -63.24 | -17.65% | -12.73% | 8.662M | 8.461M | 2.38% | 29.87% |
| Q1 2023 | -72.00 | -67.32 | -6.95% | -9.09% | 7.415M | 7.504M | -1.19% | 30.09% |
| Q4 2022 | -78.00 | -67.32 | -15.86% | -62.50% | 8.22M | 8.16M | 0.74% | 30.48% |
| Q3 2022 | -66.00 | -70.38 | 6.22% | -48.65% | 7.22M | 6.93M | 4.18% | 54.94% |
| Q2 2022 | -66.00 | -55.89 | -18.08% | -83.33% | 6.67M | 6.409M | 4.07% | 72.80% |
| Q1 2022 | -66.00 | -45.90 | -43.79% | -175.00% | 5.7M | 5.791M | -1.57% | 79.81% |
| Q4 2021 | -48.00 | -39.63 | -21.13% | -60.00% | 6.3M | 5.684M | 10.84% | 57.89% |
| Q3 2021 | -44.40 | -34.68 | -28.02% | 7.50% | 4.66M | 4.316M | 7.97% | 111.82% |
| Q2 2021 | -36.00 | -27.69 | -30.00% | 33.33% | 3.86M | 3.586M | 7.64% | 227.12% |
| Q1 2021 | -24.00 | -27.54 | 12.85% | 86.67% | 3.17M | 2.959M | 7.13% | 178.07% |
| Q4 2020 | -30.00 | -32.13 | 6.63% | - | 3.99M | 3.567M | 11.86% | - |
| Q3 2020 | -48.00 | -32.13 | -49.39% | - | 2.2M | 2.113M | 4.12% | - |
| Q2 2020 | -54.00 | -53.04 | -1.81% | - | 1.18M | 880.26K | 34.05% | - |
| Q1 2020 | -180.00 | -131.58 | -36.80% | - | 1.14M | 1.735M | -34.29% | - |
Notes
BIONANO GENOMICS INC (BNGO) last reported earnings on 11/13/2025.
BIONANO GENOMICS INC (BNGO) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, BIONANO GENOMICS INC (BNGO) has beaten EPS estimates in 3 out of 4 releases.